Agios Pharmaceuticals
AGIO
#5155
Rank
โ‚ฌ1.34 B
Marketcap
23,15ย โ‚ฌ
Share price
-0.62%
Change (1 day)
-31.02%
Change (1 year)

Revenue for Agios Pharmaceuticals (AGIO)

Revenue in 2025 (TTM): โ‚ฌ39.91 Million

According to Agios Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ37.78 Million. In 2024 the company made a revenue of โ‚ฌ35.07 Million an increase over the revenue in the year 2023 that were of โ‚ฌ24.26 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agios Pharmaceuticals from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ39.91 M13.81%
2024 โ‚ฌ35.07 M44.55%
2023 โ‚ฌ24.26 M82.78%
2022 โ‚ฌ13.27 M
2021 N/A-100%
2020 โ‚ฌ35.8 M-65.98%
2019 โ‚ฌ0.10 B27.57%
2018 โ‚ฌ82.5 M130.16%
2017 โ‚ฌ35.84 M-46.05%
2016 โ‚ฌ66.44 M22.89%
2015 โ‚ฌ54.06 M0.61%
2014 โ‚ฌ53.73 M190.49%
2013 โ‚ฌ18.49 M-2.53%
2012 โ‚ฌ18.97 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ52.96 B 140,075.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ50.12 B 132,560.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ35.72 B 94,456.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
โ‚ฌ0.14 B 273.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ1.93 B 5,008.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ2.61 B 6,807.64%๐Ÿ‡บ๐Ÿ‡ธ USA